Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxiao He

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical Laboratory|July 15, 2025
A Rare Case of AML-M1 with Positive Cup-Like Blast CellXiuping Xu, Chunxiao He
Clinical Laboratory|September 9, 2025
Sparganum-Induced Eosinophilic Pleural Effusion: a Case Report Emphasizing Laboratory Diagnostic StrategiesChunxiao He, Qing Wang, Xiuping Xu
G3 (Bethesda, Md.)|May 24, 2020
Support Vector Machine for Lung Adenocarcinoma Staging Through Variant PathwaysFeng Di, Chunxiao He, Guimei Pu, et al.
Cytotechnology|August 18, 2025
Salidroside alleviates the progression of idiopathic pulmonary fibrosis by regulating ferroptosisHomood Alharbi, Mohammad Ahmad, Liya Tu, et al.
RSC Advances|April 23, 2025
Oxygen-rich carbon cloth as a lithium deposition host for stable lithium metal anodesYan Wang, Chunxiao He, Xiaodong Sun, et al.
Head & Neck|December 12, 2013
Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinomaYing Jin, Xiao Ye, Chunxiao He, et al.
Thoracic Cancer|January 15, 2016
Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinomaZhengbo Song, Xinmin Yu, Chunxiao He, et al.
Journal of Thoracic Disease|August 31, 2013
Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancerZhengbo Song, Xinmin Yu, Chunxiao He, et al.
Open Life Sciences|October 6, 2023
ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosisYu Jiang, Jialin Shi, Junhao Zhou, et al.
Current Treatment Options in Oncology|October 23, 2024
Current Drug Resistance Mechanisms and Treatment Options in Gastrointestinal Stromal Tumors: Summary and UpdateChunxiao He, Zilong Wang, Jiaying Yu, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Laboratory|July 15, 2025
A Rare Case of AML-M1 with Positive Cup-Like Blast CellXiuping Xu, Chunxiao He
Clinical Laboratory|September 9, 2025
Sparganum-Induced Eosinophilic Pleural Effusion: a Case Report Emphasizing Laboratory Diagnostic StrategiesChunxiao He, Qing Wang, Xiuping Xu
G3 (Bethesda, Md.)|May 24, 2020
Support Vector Machine for Lung Adenocarcinoma Staging Through Variant PathwaysFeng Di, Chunxiao He, Guimei Pu, et al.
Cytotechnology|August 18, 2025
Salidroside alleviates the progression of idiopathic pulmonary fibrosis by regulating ferroptosisHomood Alharbi, Mohammad Ahmad, Liya Tu, et al.
RSC Advances|April 23, 2025
Oxygen-rich carbon cloth as a lithium deposition host for stable lithium metal anodesYan Wang, Chunxiao He, Xiaodong Sun, et al.
Head & Neck|December 12, 2013
Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinomaYing Jin, Xiao Ye, Chunxiao He, et al.
Thoracic Cancer|January 15, 2016
Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinomaZhengbo Song, Xinmin Yu, Chunxiao He, et al.
Journal of Thoracic Disease|August 31, 2013
Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancerZhengbo Song, Xinmin Yu, Chunxiao He, et al.
Open Life Sciences|October 6, 2023
ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosisYu Jiang, Jialin Shi, Junhao Zhou, et al.
Current Treatment Options in Oncology|October 23, 2024
Current Drug Resistance Mechanisms and Treatment Options in Gastrointestinal Stromal Tumors: Summary and UpdateChunxiao He, Zilong Wang, Jiaying Yu, et al.
Pageof 5